Resveratrol suppresses epithelial-to-mesenchymal transition in colorectal cancer through TGF-β1/Smads signaling pathway mediated Snail/E-cadherin expression

详细信息    查看全文

• 作者：Qing Ji ; Xuan Liu ; Zhifen Han ; Lihong Zhou ; Hua Sui ; Linlin Yan ; Haili Jiang…
• 关键词：Resveratrol ; Colorectal cancer ; Epithelial ; to ; mesenchymal transition ; TGF ; β1/Smads signaling pathway ; Snail ; E ; cadherin
• 刊名：BMC Cancer
• 出版年：2015
• 出版时间：December 2015
• 年：2015
• 卷：15
• 期：1
• 全文大小：1,915 KB
• 参考文献：1. Watson, AJ, Collins, PD (2011) Colon cancer: a civilization disorder. Dig Dis 29: pp. 222-8 CrossRef
  2. Christofori, G (2006) New signals from the invasive front. Nature 441: pp. 444-50 CrossRef
  3. Fidler, IJ (2003) The pathogenesis of cancer metastasis: the ‘seed and soil-hypothesis revisited. Nat Rev Cancer 3: pp. 453-8 CrossRef
  4. Thiery, JP (2002) Epithelial-mesenchymal transitions in tumour progression. Nat Rev Cancer 2: pp. 442-54 CrossRef
  5. Thiery, JP, Acloque, H, Huang, RY, Nieto, MA (2009) Epithelial-mesenchymal transitions in development and disease. Cell 139: pp. 871-90 CrossRef
  6. Guarion, M (2007) Epithelial-mesenchymal transition and tumour invasion. Int J Biochem Cell Biol 39: pp. 2153-60 CrossRef
  7. Wendt, MK, Schiemann, WP (2009) Therapeutic targeting of the focal adhesion complex prevents oncogenic TGF-beta signaling and metastasis. Breast Cancer Res 11: pp. R68 CrossRef
  8. Tian, M, Neil, JR, Schiemann, WP (2011) Transforming growth factor-beta and the hallmarks of cancer. Cell Signal 23: pp. 951-62 CrossRef
  9. Tirino, V, Camerlingo, R, Bifulco, K, Irollo, E, Montella, R, Paino, F (2013) TGF-beta1 exposure induces epithelial to mesenchymal transition both in CSCs and non-CSCs of the A549 cell line, leading to an increase of migration ability in the CD133+ A549 cell fraction. Cell Death Disease 4: pp. e620 CrossRef
  10. Shankar, S, Nall, D, Tang, SN, Meeker, D, Passarini, J, Sharma, J (2011) Resveratrol inhibits pancreatic cancer stem cell characteristics in human and KrasG12D transgenic mice by inhibiting pluripotency maintaining factors and epithelial-mesenchymal transition. PLoS One 6: pp. e16530 CrossRef
  11. Sun, C, Hu, Y, Liu, X, Wu, T, Wang, Y, He, W (2006) Resveratrol downregulates the constitutional activation of nuclear factor-B in multiple myeloma cells, leading to suppression of proliferation and invasion, arrest of cell cycle and induction of apoptosis. Cancer Genet Cytogenet 165: pp. 9-19 CrossRef
  12. Vergara, D, Simeone, P, Toraldo, D, Boccio, P, Vergaro, V, Leporatti, S (2012) Resveratrol downregulates Akt/GSK and ERK signaling pathways in OVCAR-3 ovarian cancer cells. Mol Biosyst 8: pp. 1078-87 CrossRef
  13. Vergara, D, Valente, CM, Tinelli, A, Siciliano, C, Lorusso, V, Acierno, R (2011) Resveratrol inhibits the epidermal growth factor-induced epithelial mesenchymal transition in MCF-7 cells. Cancer Lett 310: pp. 1-8 CrossRef
  14. Mahyar-Roemer, M, Katsen, A, Mestres, P, Roemer, K (2001) Resveratrol induces colon tumor cell apoptosis independently of p53 and precede by epithelial differentiation, mitochondrial proliferation and membrane potential collapse. Int J Cancer 94: pp. 615-22 CrossRef
  15. Delmas, D, Rebe, C, Lacour, S, Filomenko, R, Athias, A, Gambert, P (2003) Resveratrol-induced apoptosis is associated with Fas redistribution in the rafts and the formation of a death-inducing signaling complex in colon cancer cells. J Biol Chem 278: pp. 41482-90 CrossRef
  16. Ji, Q, Liu, X, Fu, XL, Zhang, L, Sui, H, Zhou, LH (2013) Resveratrol inhibits invasion and metastasis of colorectal cancer cells via MALAT1 mediated Wnt/β-catenin signal pathway. PLo
• 刊物主题：Cancer Research; Oncology; Stem Cells; Animal Models; Internal Medicine;
• 出版者：BioMed Central
• ISSN：1471-2407

文摘

Background Resveratrol extracted from grape has been an ideal alternative drug in the therapy of different cancers including colorectal cancer (CRC). Since the underlying mechanisms of resveratrol on the invasion and metastasis of CRC have not been fully elucidated, and epithelial-to-mesenchymal transition (EMT) is a key process associated with the progression of CRC, here we aimed to investigate the potential mechanism of resveratrol on the inhibition of TGF-β1-induced EMT in CRC LoVo cells. Methods We investigated the anticancer effect of resveratrol against LoVo cells in vitro and in vivo. In vivo, the impact of resveratrol on invasion and metastasis was investigated by mice tail vein injection model and mice orthotopic transplantation tumor model. In vivo imaging was applied to observe the lungs metastases, and hemaoxylin-eosin (HE) staining was used to evaluate metastatic lesions. In vitro, impact of resveratrol on the migration and invasion of LoVo cells was evaluated by transwell assay. Inhibition effect of resveratrol on TGF-β-induced EMT was examined by morphological observation. Epithelial phenotype marker E-cadherin and mesenchymal phenotype marker Vimentin were detected by western blot and immunofluorescence. Promoter activity of E-cadherin was measured using a dual-luciferase assay kit. mRNA expression of Snail and E-cadherin was measured by RT-PCR. Results We demonstrated that, resveratrol inhibited the lung metastases of LoVo cells in vivo. In addition, resveratrol reduced the rate of lung metastases and hepatic metastases in mice orthotopic transplantation. In vitro, TGF-β1-induced EMT promoted the invasion and metastasis of CRC, reduced the E-cadherin expression and elevated the Vimentin expression, and activated the TGF-β1/Smads signaling pathway. But resveratrol could inhibit the invasive and migratory ability of LoVo cells in a concentration-dependent manner, increase the expression of E-cadherin, repress the expression of Vimentin, as well as the inhibition of TGF-β1/Smads signaling pathway. Meanwhile, resveratrol reduced the level of EMT-inducing transcription factors Snail and the transcription of E-cadherin during the initiation of TGF-β1-induced EMT. Conclusions Our new findings provided evidence that, resveratrol could inhibit EMT in CRC through TGF-β1/Smads signaling pathway mediated Snail/E-cadherin expression, and this might the potential mechanism of resveratrol on the inhibition of invasion and metastases in CRC.